CARDENE IV

Baxter Healthcare Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 27, 2026
Approval ID: f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e
Products: 2 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CARDENE IV safely and effectively. See full prescribing information for CARDENE IV.CARDENE IV (nicardipine hydrochloride in dextrose injection) for intravenous useCARDENE IV (nicardipine hydrochloride in sodium chloride injection), for intravenous use Initial U.S. Approval: 1988

Quick Stats

Total Products2

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.